BioCloner Health supports the development of research technologies at Polish universities.
Recently, our company successfully implemented its proprietary 3D bioprinting technology by placing the BioCloner Desktop Pro at the Medical University of Warsaw and the AGH University of Science and Technology.
On November 6th, the modern 3D bioprinter was handed over to the team at the Faculty of Pharmacy at the Medical University of Warsaw, under the leadership of Prof. Joanna Kolmas. In a similar manner, the machine was introduced at AGH University of Science and Technology in Krakow. On November 12th, the second BioCloner Desktop Pro left our company and joined the team led by Prof. Ewa Stodolak-Zych from the Department of Biomaterials and Composites at the Faculty of Materials Engineering and Ceramics at AGH.
The 3D bioprinter, thanks to its flexibility in selecting print heads, has perfectly adapted to the needs of researchers in both fields. At the Medical University of Warsaw, it has been used in work on new drugs, while at AGH University of Science and Technology, it met the requirements of technical sciences. It is a versatile device for any laboratory and for experts from various branches of science.
The BioCloner Desktop Pro will also participate in a project carried out in collaboration between the Medical University of Warsaw and the Warsaw University of Technology. This allows for the combination of skills and knowledge from two different fields. The collaboration between the medical and technical universities aims to harness the potential of 3D bioprinting to create new standards in drug production. The combined expertise and experience of experts from both institutions accelerates the development of interdisciplinary research. It also fosters lasting connections between these environments, which could support further technological and scientific advancement.
BioCloner Health supports the development of research technologies at Polish universities.
Recently, our company successfully implemented its proprietary 3D bioprinting technology by placing the BioCloner Desktop Pro at the Medical University of Warsaw and the AGH University of Science and Technology.
On November 6th, the modern 3D bioprinter was handed over to the team at the Faculty of Pharmacy at the Medical University of Warsaw, under the leadership of Prof. Joanna Kolmas. In a similar manner, the machine was introduced at AGH University of Science and Technology in Krakow. On November 12th, the second BioCloner Desktop Pro left our company and joined the team led by Prof. Ewa Stodolak-Zych from the Department of Biomaterials and Composites at the Faculty of Materials Engineering and Ceramics at AGH.
The 3D bioprinter, thanks to its flexibility in selecting print heads, has perfectly adapted to the needs of researchers in both fields. At the Medical University of Warsaw, it has been used in work on new drugs, while at AGH University of Science and Technology, it met the requirements of technical sciences. It is a versatile device for any laboratory and for experts from various branches of science.
The BioCloner Desktop Pro will also participate in a project carried out in collaboration between the Medical University of Warsaw and the Warsaw University of Technology. This allows for the combination of skills and knowledge from two different fields. The collaboration between the medical and technical universities aims to harness the potential of 3D bioprinting to create new standards in drug production. The combined expertise and experience of experts from both institutions accelerates the development of interdisciplinary research. It also fosters lasting connections between these environments, which could support further technological and scientific advancement.
Jak przebiegło wprowadzenie BioCloner Desktop Pro na AGH?
Wdrożenie BioCloner Desktop Pro na AGH, rozpoczęły dwudniowe warsztaty prowadzone przez zespół BioCloner Health. Podczas ich trwania nasi inżynierowe skupili się na skrupulatnym wyjaśnieniu obsługi maszyny. W szkoleniach uczestniczyli zarówno pracownicy naukowi, jak i studenci drugiego i trzeciego stopnia.
Tutaj również pojawiły się świetne i innowacyjne pomysły, które stały się doskonałą okazją do wymiany doświadczeń w obszarze rozwoju technologii medycznych. Zespół z Krakowa z dużym zainteresowaniem przyjrzał się możliwościom biodruku 3D oraz funkcjom oferowanym przez nasze urządzenie. Technologia BioCloner sprzyja pracy naukowców między innymi nad opracowywaniem opatrunków i rusztowań oraz innych konstruktów inżynierii tkankowej.
Cieszymy się, że możemy z wami pracować!
Współpraca z Warszawskim Uniwersytetem Medycznym oraz z Akademią Górniczo Hutniczą w Krakowie to dla BioCloner Health krok do przodu w realizacji misji wspierania naukowców i rozwoju biodruku 3D. Nasza firma z dumą wspiera innowacyjne projekty, które realnie przyczyniają się do postępu technologii w dziedzinach medycznych i farmaceutycznych, wpływając pozytywnie na modernizację nowych terapii i poprawę jakości życia i zdrowia pacjentów.